I agree that this site is using cookies. You can find further informations here.
X
Annunziata, Mario
489  results:
Search for persons X
?
1

Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in new..:

Serio, Bianca ; Grimaldi, Francesco ; Ammirati, Lucia...
Cancer Reports.  7 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Asciminib vs bosutinib in chronic-phase chronic myeloid leu..:

Hochhaus, Andreas ; Réa, Delphine ; Boquimpani, Carla...
Leukemia.  37 (2023)  3 - p. 617-626 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Prospective monitoring of chronic myeloid leukemia patients..:

Pacelli, Paola ; Santoni, Adele ; Sicuranza, Anna...
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal ..:

De Novellis, Danilo ; Fontana, Raffaele ; Palmieri, Salvatore...
Targeted Oncology.  18 (2023)  6 - p. 885-892 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Efficacy and safety of nilotinib as frontline treatment in ..:

Luciano, Luigia ; Latagliata, Roberto ; Gugliotta, Gabriele...
Annals of Hematology.  102 (2023)  6 - p. 1375-1382 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for t..:

Fracchiolla, Nicola Stefano ; Sciumè, Mariarita ; Papayannidis, Cristina...
Cancers.  15 (2023)  18 - p. 4623 , 2023
Link: https://doi.org/10.3390/..
 
?
7

P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIA..:

Breccia, Massimo ; Russo Rossi, Antonella ; Giai, Valentina...
HemaSphere.  7 (2023)  S3 - p. e55133e1 , 2023
Link: https://doi.org/10.1097/..
 
?
8

The new Systematic Coronary Risk Evaluation (SCORE2 and SCO..:

Mulas, Olga ; Abruzzese, Elisabetta ; Luciano, Luigiana...
Annals of Hematology.  103 (2023)  2 - p. 427-436 , 2023
Link: https://doi.org/10.1007/..
 
?
9

P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREA..:

Annunziata, Mario ; Lunghi, Monia ; Giglio, Fabio...
HemaSphere.  7 (2023)  S3 - p. e53053b9 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Determinants of frontline tyrosine kinase inhibitor choice ..:

Tiribelli, Mario ; Latagliata, Roberto ; Breccia, Massimo...
Cancer.  129 (2023)  17 - p. 2637-2644 , 2023
Link: https://doi.org/10.1002/..
 
?
11

CML-395 Efficacy and Safety Results From ASCEMBL, a Phase I..:

Réa, Delphine ; Hochhaus, Andreas ; Mauro, Michael J....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S295-S296 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Haematological Drugs Affecting Lipid Metabolism and Vascula..:

Parrella, Antonio ; Iannuzzi, Arcangelo ; Annunziata, Mario...
Biomedicines.  10 (2022)  8 - p. 1935 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Poster: CML-395 Efficacy and Safety Results From ASCEMBL, a..:

Réa, Delphine ; Hochhaus, Andreas ; Mauro, Michael J....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S145 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Incidence, treatment and outcome of central nervous system ..:

Dargenio, Michelina ; Bonifacio, Massimiliano ; Chiaretti, Sabina...
British Journal of Haematology.  200 (2022)  4 - p. 440-450 , 2022
Link: https://doi.org/10.1111/..
 
?
15

Case Report: Genetic Analysis of PEG-Asparaginase Induced S..:

Iannuzzi, Arcangelo ; Annunziata, Mario ; Fortunato, Giuliana...
Frontiers in Genetics.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
1-15